Search or choose
Find the right test or package.
Intrachromosomal Amplification of Chromosome 21
Intrachromosomal Amplification of Chromosome 21 (iAMP21) is a genetic abnormality in acute myeloid leukemia (AML) characterized by extra copies of chromosome 21 within a single chromosome. iAMP21 is associated with high-risk AML and often leads to treatment re...
DiagnosticsLab test
Know more about this test
Intrachromosomal Amplification of Chromosome 21 (iAMP21) is a genetic abnormality in acute myeloid leukemia (AML) characterized by extra copies of chromosome 21 within a single chromosome. iAMP21 is associated with high-risk AML and often leads to tr...
Understanding Intrachromosomal Amplification of Chromosome 21
Intrachromosomal Amplification of Chromosome 21 (iAMP21) is a genetic abnormality in acute myeloid leukemia (AML) characterized by extra copies of chromosome 21 within a single chromosome. iAMP21 is associated with high-risk AML and often leads to treatment resistance. Detecting iAMP21 through genetic tests is important for risk stratification and tailoring treatment strategies in AML patients.
What does Intrachromosomal Amplification of Chromosome 21 measure?
Intrachromosomal Amplification of Chromosome 21 (iAMP21) is a genetic abnormality in acute myeloid leukemia (AML) characterized by extra copies of chromosome 21 within a single chromosome. iAMP21 is associated with high-risk AML and often leads to treatment resistance. Detecting iAMP21 through genetic tests is important for risk stratification and tailoring treatment strategies in AML patients.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.